Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07478263 · ClinicalTrials.gov registry record · NA
Behavioral Approach for Latinas Addressing Nutrition, Cravings, and Eating Patterns to Prevent Type 2 Diabetes
A NA study of PreDiabetes and Obesity (Body Mass Index >30 kg/m2), sponsored by University of California, San Diego.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT07478263: Recruiting NA study of PreDiabetes and Obesity (Body Mass Index >30 kg/m2), sponsored by University of California, San Diego.
NCT07478263 is a NA study of PreDiabetes and Obesity (Body Mass Index >30 kg/m2) that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 30 participants, below the 701-participant average among 149 other PreDiabetes trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07478263, a NA study of PreDiabetes and Obesity (Body Mass Index >30 kg/m2), is actively recruiting participants, sponsored by University of California, San Diego.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Adapt the Regulation of Cues (ROC) treatment program for Latinas to see if it can treat prediabetes and prevent developing of Type 2 Diabetes and reduce weight.
Primary Outcome
Participants rating of acceptability of the treatment via questionnaire with item on a 5-point likert scale indicating ranked from 1 - strongly disagree to 5 - strongly agree that the treatment was helpful - higher values equal greater acceptability of treatment
Conditions Studied
Interventions
- BEHAVIORAL Regulation of Cues
Study Locations (1)
California
- UCSD Center for Healthy Eating and Activity Research (CHEAR - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-03-31 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
What NCT07478263 shows while recruiting
NCT07478263 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 701-participant average among 149 other PreDiabetes trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with PreDiabetes appearing as the primary indexed condition, and to 1 intervention - of which Regulation of Cues is the first listed.
NCT07478263 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07478263 about?
NCT07478263 is a clinical study titled "Behavioral Approach for Latinas Addressing Nutrition, Cravings, and Eating Patterns to Prevent Type 2 Diabetes". Adapt the Regulation of Cues (ROC) treatment program for Latinas to see if it can treat prediabetes and prevent developing of Type 2 Diabetes and reduce weight.
What is the current status of trial NCT07478263?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-03-31. Estimated completion is 2027-06-30.
What conditions does trial NCT07478263 study?
This clinical trial studies the following conditions: PreDiabetes, Obesity (Body Mass Index >30 kg/m2).
What interventions are being tested in trial NCT07478263?
The interventions under investigation include: Regulation of Cues (BEHAVIORAL).
Who is sponsoring clinical trial NCT07478263?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07478263 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PreDiabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07478263's enrollment target sits among peer trials
30 118th of 149 higher than 23 of 149 other PreDiabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PreDiabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
Diabetes Clinical Decision Support
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
-
Cleaner Air for Lower Cardiometabolic Risk
RECRUITING · NA
-
Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI